Microarray classification of myelodysplastic syndrome (MDS) identifies subgroups with distinct clinical outcomes and identifies patients with high risk of AML transformation Mills KI, Kohlmann A, Williams M, Wieczorek L, Liu WM, Li R, Wen W, Bowen DT, Loeffler H, Hernández Rivas JM, Hofmann WK, Haferlach T. Blood 114(5):1063-72. FI: 10.555 (Q1) Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205 Flis S, Gnyszka A, Misiewicz-Krzemiska I, Sp.awi.ski J. Cancer Cell International 09:10. FI: 2.030 (Q3) The effect of isothiocyanates on CYP1A1 and CYP1A2 activities induced by polycyclic aromatic hydrocarbons in Mcf7 cells Skupinska K, Misiewicz-Krzemiska I, Lubelska K, Kasprzycka-Guttman T. Toxicology in Vitro 23(5):763-71. FI: 2.060 (Q3) International Myeloma Working Group molecular classification of multiple myeloma: spotlight review Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutiérrez NC, Stewart K, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H. Leukemia 23(12):2210-21. FI: 8.296 (Q1) GeneCBR: a translational tool for multiple-microarray analysis and integrative information retrieval for aiding diagnosis in cancer research González-Peña D, Díaz F, Hernández JM, Corchado JM, Fdez-Riverola F. BMC Bioinformatics 10:18. FI: 3.428 (Q1) Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response Sánchez-Guijo FM, Hernández Rivas JM, Lumbreras E, Morais P, Santamaría C, García JL, Gutiérrez NC, Miguel JF, Del Cañizo MC. Leukemia Research 33(1):170-3. FI: 2.358 (Q3) A high number of losses in 13q14 chromosome is associated with a worse outcome and biological differences in patients with B chronic lymphoid leukemia (B-CLL) Hernández JA, Rodríguez AE, González M, Benito R, Fontanillo C, Sandoval V, Romero M, Martín-Núñez G, de Coca AG, Fisac R, Galende J, Recio I, Ortuño F, García JL, de las Rivas J, Gutiérrez NC, San Miguel JF, Hernández JM. Haematologica 94(3):364-71. FI: 6.416 (Q1) Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome Lopez-Villar O, García JL, Sánchez-Guijo FM, Robledo C, Villaron EM, Hernández-Campo P, Lopez-Holgado N, Diez-Campelo M, Barbado MV, Pérez-Simon JA, Hernández Rivas JM, San-Miguel JF, del Cañizo MC. Leukemia 23(4):664-72. FI: 8.296 (Q1) Spanish Lymphoma/ Autologous Bone Marrow Transplant Study Group (GEL-TAMO). Array CGH identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas Robledo C, García JL, Caballero D, Conde E, Arranz R, Flores T, Grande C, Rodríguez J, García E, Sáez AI, González M, Gutiérrez NC, Piris MA, Hernández JM. Cancer 115(16):3728-37. FI: 5.418 (Q1) Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for DLBCL patients Saez AI, García-Cosío M, Sáez AJ, Hernández JM, Sánchez-Verde L, Alvarez D, de la Cueva P, Arranz R, Conde E, Grande C, Rodríguez J, Caballero D, Piris MA. Leukemia & Lymphoma 50(4):571-81. FI: 2.397 (Q3)
|
